Hantz Financial Services’s Integra LifeSciences IART Stock Holding History

Hantz Financial Services’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$19K	Buy	1,080 +139	+15%	+$1.94K	﹤0.01%	1955
2026 Q1	$9K	Buy	941 +592	+170%	+$6.5K	﹤0.01%	2070
2025 Q4	$4K	Sell	349 -98	-22%	-$1.3K	﹤0.01%	2175
2025 Q3	$6K	Buy	447 +290	+185%	+$3.97K	﹤0.01%	1971
2025 Q2	$2K	Buy	+157	New	+$2.28K	﹤0.01%	1988
2022 Q4	–	Sell	-5,626	Closed	-$238K	–	1114
2022 Q3	$238K	Buy	5,626 +2,979	+113%	+$153K	0.01%	500
2022 Q2	$143K	Buy	+2,647	New	+$159K	﹤0.01%	533

Other funds holding IART

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

PCMI

Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

Hantz Financial Services's IART Position: Q2 2026 in Review

Hantz Financial Services increased its Integra LifeSciences (IART) stake by 15% in Q2 2026, buying an estimated $1.94K and bringing the position to 1,080 shares worth $19K. The position accounts for ﹤0.01% of the portfolio, ranked #1955.

Hantz Financial Services first reported a position in IART in Q2 2022 and has held it in 7 quarters since. The position peaked at $238K in Q3 2022. 213 funds tracked by Wall St. Rank hold IART as of Q2 2026.

Hantz Financial Services held 1,080 shares of Integra LifeSciences worth $19K as of Q2 2026.
Hantz Financial Services bought 139 Integra LifeSciences shares in Q2 2026, an estimated $1.94K.
Integra LifeSciences made up ﹤0.01% of Hantz Financial Services's portfolio in Q2 2026, its #1955 holding.
Hantz Financial Services first reported a position in Integra LifeSciences in Q2 2022 and has held it in 7 quarters since.
Hantz Financial Services's Integra LifeSciences position peaked at $238K in Q3 2022.
213 funds tracked by Wall St. Rank held Integra LifeSciences as of Q2 2026.

Based on Hantz Financial Services's 13F filing for Q2 2026, filed 13 Aug 2026.